Polarized Light Therapy for Radiation Dermatitis in Breast Cancer

This assessor-blinded randomized controlled trial aims to evaluate the efficacy of polarized polychromatic non-coherent light therapy as an adjunct to standard skin care in reducing acute radiation dermatitis in women with breast cancer undergoing hypofractionated whole-breast radiotherapy. Participants will be randomly allocated to receive either standard skin care alone or standard care combined with polarized light therapy initiated from the first radiotherapy session. Outcomes will include objective ultrasound-based dermal thickness measurements, clinical severity of radiation dermatitis u

Trial Details

NCT ID
NCT07600957
Phase
NA
Sponsor
Beni-Suef University
Status
RECRUITING
Cancer Type
Breast Cancer
Interventions
  • Polarized Polychromatic Light Therapy
  • Standard Skin Care
Locations (sample)
  • Banī Suwayf, Egypt|29.07441,31.09785

Key Eligibility Criteria

  • Female patients aged 35-55 years.
  • Histologically confirmed primary unilateral breast cancer.
  • Status post breast-conserving surgery (lumpectomy).
  • Planned for hypo fractionated whole-breast irradiation (HFWBI).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Breast Cancer Trials on Trialify →